NYSE:BSXMedical Equipment
Boston Scientific Governance Shift Raises Questions On Investor Influence
Boston Scientific (NYSE:BSX) stockholders approved the removal of supermajority voting requirements at a recent shareholder meeting.
Shareholders also adopted officer exculpation protections and approved new shares for the Employee Stock Purchase Plan.
Proposals to allow shareholders to call special meetings and other changes to shareholder rights were put forward but did not pass.
Boston Scientific enters these governance changes with its stock at $56.57 and a mixed return profile. The...